ArticleCancer immunology, immunotherapy : CII2025
Early trajectory of inflammatory cytokines following tarlatamab administration in three advanced SCLC patients.
Takuma Imakita et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it